156 related articles for article (PubMed ID: 1869978)
1. PET cancer evaluations with FDG.
Hawkins RA; Hoh C; Dahlbom M; Choi Y; Glaspy J; Tse N; Slamon D; Chen B; Messa C; Maddahi J
J Nucl Med; 1991 Aug; 32(8):1555-8. PubMed ID: 1869978
[No Abstract] [Full Text] [Related]
2. Fluorodeoxyglucose (FDG) and tumour metabolism.
Van Wyngaarden KE; Pauwels EK
Nucl Med Commun; 1995 Dec; 16(12):987-9. PubMed ID: 8719978
[No Abstract] [Full Text] [Related]
3. [Diagnosis of cancers by FDG-PET].
Ichiya Y
Fukuoka Igaku Zasshi; 1997 Jan; 88(1):7-10. PubMed ID: 9091463
[No Abstract] [Full Text] [Related]
4. Quantitating tumor glucose metabolism with FDG and PET.
Hawkins RA; Choi Y; Huang SC; Messa C; Hoh CK; Phelps ME
J Nucl Med; 1992 Mar; 33(3):339-44. PubMed ID: 1740699
[No Abstract] [Full Text] [Related]
5. Use of positron emission tomography in oncology.
Glaspy JA; Hawkins R; Hoh CK; Phelps ME
Oncology (Williston Park); 1993 Jul; 7(7):41-6, 49-50; discussion 50-2, 55. PubMed ID: 8347460
[TBL] [Abstract][Full Text] [Related]
6. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.
Rigo P; Paulus P; Kaschten BJ; Hustinx R; Bury T; Jerusalem G; Benoit T; Foidart-Willems J
Eur J Nucl Med; 1996 Dec; 23(12):1641-74. PubMed ID: 8929320
[TBL] [Abstract][Full Text] [Related]
7. [Use of positron-emission tomography in oncology].
Strauss LG; Kabelitz D; Kremer B; Lode H; Meinertz T; Sauerbruch T; Sterry W
Dtsch Med Wochenschr; 1996 Feb; 121(7):207-9. PubMed ID: 8681765
[No Abstract] [Full Text] [Related]
8. Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?
Brock CS; Meikle SR; Price P
Eur J Nucl Med; 1997 Jun; 24(6):691-705. PubMed ID: 9169580
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET in oncology: there's more to it than looking at pictures.
Fischman AJ; Alpert NM
J Nucl Med; 1993 Jan; 34(1):6-11. PubMed ID: 8418272
[No Abstract] [Full Text] [Related]
10. SUV: standard uptake or silly useless value?
Keyes JW
J Nucl Med; 1995 Oct; 36(10):1836-9. PubMed ID: 7562051
[No Abstract] [Full Text] [Related]
11. Positron emission tomographic oncology.
Lawson MA
West J Med; 1994 Oct; 161(4):411-2. PubMed ID: 7817554
[No Abstract] [Full Text] [Related]
12. Is there a future for PET in oncology?
Price P
Eur J Nucl Med; 1997 Jun; 24(6):587-9. PubMed ID: 9235296
[No Abstract] [Full Text] [Related]
13. [Potential use of positron-emission tomography in clinical oncology].
Fukuda H; Matsuzawa T; Tateno Y
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):860-5. PubMed ID: 3291774
[TBL] [Abstract][Full Text] [Related]
14. Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies.
Shulkin BL; Mitchell DS; Ungar DR; Prakash D; Dole MG; Castle VP; Hernandez RJ; Koeppe RA; Hutchinson RJ
Radiology; 1995 Feb; 194(2):495-500. PubMed ID: 7824731
[TBL] [Abstract][Full Text] [Related]
15. Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET.
Macfarlane DJ; Cotton L; Ackermann RJ; Minn H; Ficaro EP; Shreve PD; Wahl RL
Radiology; 1995 Feb; 194(2):425-9. PubMed ID: 7824722
[TBL] [Abstract][Full Text] [Related]
16. [Positron emitters for the study of tumor metabolism].
Strauss LG
Radiologe; 1989 Jul; 29(7):318-21. PubMed ID: 2667030
[TBL] [Abstract][Full Text] [Related]
17. PET FDG studies in oncology.
Hawkins RA; Hoh CK
Nucl Med Biol; 1994 Jul; 21(5):739-47. PubMed ID: 9241650
[TBL] [Abstract][Full Text] [Related]
18. Cancer or inflammation? A Holy Grail for nuclear medicine.
Larson SM
J Nucl Med; 1994 Oct; 35(10):1653-5. PubMed ID: 7931666
[No Abstract] [Full Text] [Related]
19. PET and [18F]-FDG in oncology: a clinical update.
Conti PS; Lilien DL; Hawley K; Keppler J; Grafton ST; Bading JR
Nucl Med Biol; 1996 Aug; 23(6):717-35. PubMed ID: 8940714
[TBL] [Abstract][Full Text] [Related]
20. [Cancer diagnosis with positron emission tomography (PET)].
Kubota K
Kaku Igaku; 1996 Feb; 33(2):207-12. PubMed ID: 8721109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
